Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term ...

Recent innovations, successful trials, and increased research and development spending in the healthcare sector further boost ...

In particular, new FDA requirements around modifying IVDs could lead labs to push for IVD vendors to validate their tests ...

Beckman Coulter Life Sciences and Illumina announced the launch of the Illumina TruSight Oncology 500 DNA/ RNA assay on the ...

The Global DNA and RNA Extraction Market is projected to reach USD 7.9 billion in 2024 and is expected to grow to USD 16.4 ...

Furthermore, Brennan was encouraged by the specific growth initiatives discussed for key players within the Dx segment like Cepheid and Beckman Coulter. Projections for Cepheid’s growth in the low ...

His assessment took into account Danaher’s recent Analyst Day revelations which highlighted the strengths of its Diagnostic (Dx) franchise, particularly Cepheid and Beckman Coulter. Despite the ...

Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term ...

Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term ...

Astrocytes in the brain exhibit significant regional diversity, but the mechanisms controlling their heterogeneity remain ...